CompletedPhase 2NCT01474746
Trial of Sertraline to Treat Children With Fragile X Syndrome
Studying Fragile X syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Randi J. Hagerman, MD
- Principal Investigator
- Randi J Hagerman, MDUC Davis MIND Institute
- Intervention
- Sertraline(drug)
- Enrollment
- 57 enrolled
- Eligibility
- All sexes
- Timeline
- 2012 – 2015
Study locations (1)
- UC Davis M.I.N.D. Institute, Sacramento, California, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01474746 on ClinicalTrials.govOther trials for Fragile X syndrome
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07493096Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal DisordersHealing Hope International
- RECRUITINGPHASE2NCT07209462Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)Mirum Pharmaceuticals, Inc.
- RECRUITINGNANCT06868979Optical Imaging in X-linked Disorders.Hospices Civils de Lyon
- RECRUITINGNANCT06740162Physical Activity and Community EmPOWERment ProjectUniversity of North Carolina, Chapel Hill
- RECRUITINGPHASE2NCT06081348Sertraline vs. Placebo in the Treatment of Anxiety in Children and AdoLescents With NeurodevelopMental DisordersHolland Bloorview Kids Rehabilitation Hospital
- RECRUITINGNANCT06279858Probiotic Intervention for Microbiome Modifications and Clinical Improvements in Fragile X SyndromeSpecila hospital for cerebral palsy and developmental neurology
- RECRUITINGNANCT06088589Speech-in-noise Perception in Autism and Fragile XChildren's Hospital Medical Center, Cincinnati
- RECRUITINGNANCT06139172Web Intervention for Parents of Youth With Genetic Syndromes (WINGS)Rush University Medical Center